Immune-Mediated Organ-Specific Reactions to COVID-19 Vaccines: A Retrospective Descriptive Study
- PMID: 37242502
- PMCID: PMC10222899
- DOI: 10.3390/ph16050720
Immune-Mediated Organ-Specific Reactions to COVID-19 Vaccines: A Retrospective Descriptive Study
Abstract
Severe acute respiratory syndrome coronavirus 2 caused the global COVID-19 pandemic and public health crisis, and it led to the rapid development of COVID-19 vaccines, which can cause rare and typically mild hypersensitivity reactions (HRs). Delayed HRs to COVID-19 vaccines have been reported, and the excipients polyethylene glycol (PEG)2000 and polysorbate 80 (P80) are the suspected culprits. Skin patch tests do not help in diagnosing delayed reactions. We aimed to perform lymphocyte transformation tests (LTT) with PEG2000 and P80 in 23 patients with suspected delayed HRs. Neurological reactions (n = 10) and myopericarditis reactions (n = 6) were the most frequent complications. Seventy-eight percent (18/23) of the study patients were admitted to a hospital ward, and the median time to discharge was 5.5 (IQR, 3-8) days. Some 73.9% of the patients returned to baseline condition after 25 (IQR, 3-80) days. LTT was positive in 8/23 patients (5/10 neurological reactions, 2/4 hepatitis reactions and 1/2 rheumatologic reactions). All myopericarditis cases had a negative LTT. These preliminary results indicate that LTT with PEGs and polysorbates is a useful tool for identifying excipients as causal agents in HRs to COVID-19 vaccines and can play an important role in risk stratification in patients with HRs.
Keywords: COVID-19 vaccines; adverse drug reactions; causality algorithms; delayed hypersensitivity reactions; lymphocyte transformation test.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Organ-specific immune-mediated reactions to polyethylene glycol and polysorbate excipients: three case reports.Front Pharmacol. 2024 Jan 3;14:1293294. doi: 10.3389/fphar.2023.1293294. eCollection 2023. Front Pharmacol. 2024. PMID: 38235115 Free PMC article.
-
The role of lymphocyte transformation tests (LTT) in suspected severe delayed hypersensitivity reactions following COVID-19 vaccination.Hum Vaccin Immunother. 2023 Dec 31;19(1):2182527. doi: 10.1080/21645515.2023.2182527. Epub 2023 Mar 13. Hum Vaccin Immunother. 2023. PMID: 36912718 Free PMC article.
-
The role of skin tests with polyethylene glycol and polysorbate 80 in the vaccination campaign for COVID-19: results from an Italian multicenter survey.Eur Ann Allergy Clin Immunol. 2024 Jan;56(1):17-25. doi: 10.23822/EurAnnACI.1764-1489.291. Epub 2023 Mar 16. Eur Ann Allergy Clin Immunol. 2024. PMID: 36927838
-
COVID-19 Vaccine-associated Anaphylaxis and Allergic Reactions: Consensus Statements of the KAAACI Urticaria/Angioedema/Anaphylaxis Working Group.Allergy Asthma Immunol Res. 2021 Jul;13(4):526-544. doi: 10.4168/aair.2021.13.4.526. Allergy Asthma Immunol Res. 2021. PMID: 34212542 Free PMC article. Review.
-
Immediate Hypersensitivity Reactions Induced by COVID-19 Vaccines: Current Trends, Potential Mechanisms and Prevention Strategies.Biomedicines. 2022 May 28;10(6):1260. doi: 10.3390/biomedicines10061260. Biomedicines. 2022. PMID: 35740283 Free PMC article. Review.
Cited by
-
Neurological manifestations of immune origin after COVID-19 vaccination: retrospective case study.Front Pharmacol. 2024 Aug 8;15:1376474. doi: 10.3389/fphar.2024.1376474. eCollection 2024. Front Pharmacol. 2024. PMID: 39175548 Free PMC article.
-
Organ-specific immune-mediated reactions to polyethylene glycol and polysorbate excipients: three case reports.Front Pharmacol. 2024 Jan 3;14:1293294. doi: 10.3389/fphar.2023.1293294. eCollection 2023. Front Pharmacol. 2024. PMID: 38235115 Free PMC article.
-
Disproportionality Analysis of the Five Most Widespread Neurological Effects of COVID-19 Vaccines from 2021 to 2023: Insights from EudraVigilance.Pharmaceuticals (Basel). 2025 Apr 27;18(5):636. doi: 10.3390/ph18050636. Pharmaceuticals (Basel). 2025. PMID: 40430457 Free PMC article.
References
Grants and funding
LinkOut - more resources
Full Text Sources